Evidence mapPaperPMID 41495323Full record

ArticleScientific reports2026

Low-density lipoprotein cholesterol drives multinucleated giant cell formation in response to mycobacterium bovis Bacille Calmette-Guérin.

Philipp-Alexander Merck, Anne Kathrin Lösslein, Jana Neuber, Stephan Schwer, Wenke Jonas, John Andrew Pospisilik, Ingo Hilgendorf, Philipp Henneke, Florens Lohrmann

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Philipp-Alexander MerckMedical Faculty, Institute for Infection Prevention and Control, University Medical Center, University of Freiburg, Freiburg, Germany.
Anne Kathrin LössleinMedical Faculty, Institute for Infection Prevention and Control, University Medical Center, University of Freiburg, Freiburg, Germany.
Jana NeuberMedical Faculty, Institute for Infection Prevention and Control, University Medical Center, University of Freiburg, Freiburg, Germany.
Stephan SchwerMedical Faculty, Institute for Infection Prevention and Control, University Medical Center, University of Freiburg, Freiburg, Germany.
Wenke JonasDepartment of Experimental Diabetology, German Institute of Human Nutrition, Potsdam-Rehbrücke, Germany.
John Andrew PospisilikMax Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany; and Department of Epigenetics, Van Andel Institute, Grand Rapids, USA.
Ingo HilgendorfDepartment of Cardiology and Angiology, Faculty of Medicine, University Heart Center Freiburg-Bad Krozingen, University of Freiburg, Freiburg, Germany.
Philipp Henneke *Medical Faculty, Institute for Infection Prevention and Control, University Medical Center, University of Freiburg, Freiburg, Germany.
Florens Lohrmann *Medical Faculty, Institute for Infection Prevention and Control, University Medical Center, University of Freiburg, Freiburg, Germany. florens.lohrmann@uniklinik-freiburg.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages play a central role in tuberculosis, both in bacterial persistence and tissue pathology. Body weight and a dysregulated lipid metabolism profoundly affect disease progression and survival. Yet, the relationship between lipid metabolism and mycobacterial immunity is still poorly understood. Accordingly, this study investigated the influence of cholesterol and lipoproteins on macrophage responses to mycobacteria, in particular the formation of multinucleated giant cells (MGC), which are key components of granulomas and involved in the containment of mycobacteria. We found that low-density lipoprotein (LDL) cholesterol was essential for the transformation of macrophage progenitors into MGCs in vitro, independent of the oxidation status. In contrast to these direct lipid effects on macrophage transformation, a lipid-rich diet to mice, which is known to elevate cholesterol levels in the blood, did not prime the MGC forming potential of bone-marrow progenitor cells. In conclusion, LDL promotes the mycobacteria-specific macrophage transformation, however, this effect appears to depend on tissue lipid availability rather than priming in the bone marrow.

Indexed as

Cholesterol, LDLGiant CellsMycobacterium bovisTuberculosisAnimalsMacrophagesMiceMice, Inbred C57BLCholesterol, LDL

Identifiers

PMID41495323
PMCPMC12780115

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.